Most scientists acknowledge that ESCs will not provide therapies for many years, if ever. Their therapeutic potential is, at best, speculative. They cannot be used now, even in clinical trials, because of their tendency to produce tumors. So it comes as no surprise that many scientists now admit that their primary interest in pursuing ESC research lies not in the hope for direct cell transplant therapies, but in the desire to enhance basic scientific knowledge of such things as cell signaling, tissue growth and early human development.
The Baltimore Sun has an article about the importance of words in the stem cell debate.
California's U.S. Senator Dianne Feinstein delusionally thinks embryonic stem cell researchers are "handcuffed" even though her state will be doling out billions of dollars to them in the next decade. We should also know that "the hopes of millions of Americans depend on" President Bush changing his mind about the federal funding of killing human embryos.